Skip to content Skip to search Skip to footer
Washington University School of Medicine in St. Louis

Department of Neurology

Miller Laboratory

Menu
  • About
    • About the Miller Lab
    • Lab Members
    • Lab Alumni
    • Our Commitment to Diversity, Equity, and Inclusion
  • ALS Research
  • Dementia Research
  • Publications
  • News
    • News
    • ALS Center Newsletters
  • Donate
  • Contact
    • Contact Us
    • Lab Openings

Category: Media

Experimental drug shows promising results for rare form of ALS (Links to an external site)

July 9, 2020October 2, 2020

Researchers led by a Washington University neurologist found promising results for an experimental drug to treat a rare, inherited form of amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease.

Research in St. Louis leads to promise in the fight against ALS (Links to an external site)

July 9, 2020October 2, 2020

ST. LOUIS – Research taking place at Washington University’s School of Medicine is giving hope to those affected by amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.

Miller Laboratory

Department of Neurology

4559 Scott Ave

Biotech Building, Room 115

St. Louis, MO 63110

MillerLab@wustl.edu

  • Twitter

Stay Connected

Join our email list to receive newsletters
and updates from the ALS Center and Miller Laboratory.

Sign Up Now

To learn more about our patient care services visit the ALS Center website.

Make A Difference

Your thoughtful contribution enables us to continue researching possible treatments and ultimately cures for devastating diseases.

Donate

©2023 Washington University in St. Louis